A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax
Abstract Plasmodium vivax (P. vivax) is the major malaria parasite outside of Africa and no vaccine is available against it. A vaccine that interrupts parasite transmission (transmission-blocking vaccine, TBV) is considered highly desirable to reduce the spread of P. vivax and to accelerate its elim...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Nature Portfolio
2023-12-01
|
| سلاسل: | npj Vaccines |
| الوصول للمادة أونلاين: | https://doi.org/10.1038/s41541-023-00786-9 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|